[go: up one dir, main page]

DK0876482T3 - IL-13-receptorpolypeptid - Google Patents

IL-13-receptorpolypeptid

Info

Publication number
DK0876482T3
DK0876482T3 DK96938273T DK96938273T DK0876482T3 DK 0876482 T3 DK0876482 T3 DK 0876482T3 DK 96938273 T DK96938273 T DK 96938273T DK 96938273 T DK96938273 T DK 96938273T DK 0876482 T3 DK0876482 T3 DK 0876482T3
Authority
DK
Denmark
Prior art keywords
receptor polypeptide
polypeptide
receptor
Prior art date
Application number
DK96938273T
Other languages
Danish (da)
English (en)
Inventor
Daniel Caput
Pascual Ferrara
Patrick Laurent
Natalio Vita
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0876482(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0876482T3 publication Critical patent/DK0876482T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK96938273T 1995-12-06 1996-11-07 IL-13-receptorpolypeptid DK0876482T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9514424A FR2742156A1 (fr) 1995-12-06 1995-12-06 Polypeptide recepteur de l'il-13
PCT/FR1996/001756 WO1997020926A1 (fr) 1995-12-06 1996-11-07 Polypeptide recepteur de l'il-i3

Publications (1)

Publication Number Publication Date
DK0876482T3 true DK0876482T3 (da) 2003-07-21

Family

ID=9485198

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96938273T DK0876482T3 (da) 1995-12-06 1996-11-07 IL-13-receptorpolypeptid

Country Status (19)

Country Link
US (4) US7928073B2 (no)
EP (1) EP0876482B1 (no)
JP (3) JP3415162B2 (no)
AR (2) AR004860A1 (no)
AT (1) ATE234922T1 (no)
AU (1) AU7576096A (no)
BR (1) BR9611697B1 (no)
CA (1) CA2238893C (no)
DE (1) DE69626859T2 (no)
DK (1) DK0876482T3 (no)
ES (1) ES2192620T3 (no)
FR (1) FR2742156A1 (no)
MX (1) MX9804419A (no)
MY (1) MY123740A (no)
NO (3) NO324775B1 (no)
PT (1) PT876482E (no)
TW (1) TW565570B (no)
WO (1) WO1997020926A1 (no)
ZA (1) ZA9610238B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911530B1 (en) 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
ES2334408T3 (es) * 1995-10-23 2010-03-09 Zenyth Operations Pty Ltd Receptor de hematopoyetina y secuencias geneticas que lo codifican.
US7078494B1 (en) 1996-03-01 2006-07-18 Genetics Institute, Llc Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
EP0812913A3 (en) * 1996-06-12 1999-08-04 Smithkline Beecham Corporation HR-1 receptor, a receptor of the cytokine receptors family
WO1998010638A1 (en) * 1996-09-10 1998-03-19 Amrad Operations Pty. Ltd. Therapeutic molecules
US6743604B1 (en) 1996-12-13 2004-06-01 Smithkline Beecham Corporation Substances and their uses
GB9625899D0 (en) * 1996-12-13 1997-01-29 Glaxo Group Ltd Substances and their uses
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
CA2235420A1 (en) 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
DE69933696T2 (de) * 1998-12-14 2007-08-23 Genetics Institute, LLC, Cambridge Cytokinrezeptor-kette
AU2001236892A1 (en) * 2000-02-08 2001-08-20 The Penn State Research Foundation Immunotherapy using interleukin 13 receptor subunit alpha 2
AU2001253282A1 (en) 2000-04-07 2001-10-23 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
CN1688340A (zh) 2002-07-15 2005-10-26 韦思公司 调节t辅助(th)细胞发育和功能的方法和组合物
CA2551110C (en) 2003-12-23 2016-01-19 Tanox, Inc. Treatment of cancer with novel anti-il 13 monoclonal antibodies
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
ES2450929T3 (es) 2004-10-29 2014-03-25 Topigen Pharmaceuticals Inc. Oligonucleótidos antisentido para tratar la alergia y la proliferación de las células neoplásicas
AU2005307831A1 (en) 2004-11-17 2006-05-26 Amgen, Inc. Fully human monoclonal antibodies to IL-13
GB0615881D0 (en) * 2006-08-10 2006-09-20 Univ Southampton Novel peptide for treatment of asthma
WO2008131376A2 (en) * 2007-04-23 2008-10-30 Wyeth Methods and compositions for treating and monitoring treatment of il-13-associated disorders
US9512194B2 (en) 2012-01-27 2016-12-06 The Board Of Trustees Of The Leland Stanford Junior University Modified IL-13 polypeptides
WO2014074186A2 (en) 2012-08-09 2014-05-15 The Board Of Trustees Of The Leland Stanford Junior University Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities
WO2014152361A1 (en) 2013-03-15 2014-09-25 Wake Forest University Health Sciences Antibodies against human and canine il-13ra2
EP3683232A1 (en) 2013-09-13 2020-07-22 F. Hoffmann-La Roche AG Methods and compositions comprising purified recombinant polypeptides
MX2016002799A (es) 2013-09-13 2016-05-26 Genentech Inc Composiciones y metodos para detectar y cuantificar la proteina en la celula hospedera en las lineas de celulas y productos de polipeptidos recombinantes.
WO2015042705A1 (en) 2013-09-24 2015-04-02 Medicenna Biopharma Inc. Interleukin-4 receptor-binding fusion proteins and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
ES2136092T3 (es) * 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US5596072A (en) 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
US5587459A (en) * 1994-08-19 1996-12-24 Regents Of The University Of Minnesota Immunoconjugates comprising tyrosine kinase inhibitors
US6911530B1 (en) * 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain

Also Published As

Publication number Publication date
AU7576096A (en) 1997-06-27
NO982550L (no) 1998-08-05
CA2238893A1 (fr) 1997-06-12
NO324775B1 (no) 2007-12-10
ZA9610238B (en) 1998-06-05
JP3737793B2 (ja) 2006-01-25
FR2742156A1 (fr) 1997-06-13
DE69626859T2 (de) 2003-12-24
ATE234922T1 (de) 2003-04-15
NO328197B1 (no) 2010-01-04
US20060035856A1 (en) 2006-02-16
ES2192620T3 (es) 2003-10-16
JPH11511028A (ja) 1999-09-28
EP0876482A1 (fr) 1998-11-11
EP0876482B1 (fr) 2003-03-19
US20050282216A1 (en) 2005-12-22
MY123740A (en) 2006-06-30
CA2238893C (fr) 2013-10-08
BR9611697B1 (pt) 2013-09-17
PT876482E (pt) 2003-07-31
TW565570B (en) 2003-12-11
US20110201029A1 (en) 2011-08-18
NO982550D0 (no) 1998-06-04
BR9611697A (pt) 1999-02-17
WO1997020926A1 (fr) 1997-06-12
AR004860A1 (es) 1999-03-10
DE69626859D1 (de) 2003-04-24
US8318910B2 (en) 2012-11-27
NO20092994L (no) 1998-08-05
MX9804419A (es) 1998-09-30
US20060035855A1 (en) 2006-02-16
JP3415162B2 (ja) 2003-06-09
JP2003180382A (ja) 2003-07-02
JP4185070B2 (ja) 2008-11-19
NO20074034L (no) 1998-08-05
US7928073B2 (en) 2011-04-19
NO331148B1 (no) 2011-10-24
JP2005323595A (ja) 2005-11-24
AR056723A2 (es) 2007-10-17

Similar Documents

Publication Publication Date Title
DK0876482T3 (da) IL-13-receptorpolypeptid
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DE69601322D1 (de) Verankerungselement
FI960953A0 (fi) Endoteliinireseptoriantagonisteja
DE69735926D1 (de) Interleukin-18 Rezeptorproteine
DK46595A (da) Vibrator
FI970633L (fi) Glutamaattireseptori
ATE258548T1 (de) Adhäsionsrezeptor-antagonisten
NO976058L (no) Rekombinant mistellectin
DE69613737D1 (de) Vibrationsgerät
NO980566D0 (no) Allergen-XCD32 fusjonsproteiner
EP0754191A4 (en) NOVEL RECEPTOR TYPE PHOSPHOTYROSIN PHOSPHATASE-KAPPA
BR9609671A (pt) Amino uracilas substituídas
FR2733430B1 (fr) Retroverseur pelvien
DE69636597D1 (de) Endothelin rezeptor antagonisten
DE69616364D1 (de) Endothelinrezeptorantagonisten
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
NO981051D0 (no) Peptidderivater
NO965329D0 (no) Vibrator
BR9510060A (pt) Receptor
DE69615850D1 (de) G-protein-gekoppelter rezeptor hnfd578
FI951187L (fi) Istuin
KR970031728U (ko) 암레스트 고정구조
GB9511109D0 (en) Receptor proteins